CMHC Podcast Cardiometabolic Beat

Clinical Pearls for Individualizing T2DM Therapy with SGLT2 Inhibitors and GLP-1 RAs

Listen in as Dr. Vanita Aroda, Director of Diabetes Clinical Research at the Brigham and Women’s Hospital in Boston and faculty at Harvard Medical School, covers the ever-changing landscape and paradigm shifts in the management of patients with type 2 diabetes.

Recorded September 14, 2021

Podcast also available on:

COVID-19 and New-Onset Diabetes

Listen in as Dr. Irl Hirsch, Professor of Medicine and Diabetes Treatment and Teaching Chair at the University of Washington Medical Center in Seattle, WA., presents on an intriguing topic, that of new-onset diabetes due to COVID-19.

Recorded September 21, 2021.

Podcast also available on:

VTE: A Discussion on Screening, Prevention, and Transition of Care

Listen in as Dr. Geoffrey Barnes, Assistant Professor of Medicine, as well as a cardiologist and vascular medicine specialist at the University of Michigan Health system, shares his clinical perspectives on the prevention and management of venous thromboembolism (VTE).
Recorded September 16, 2021.

Podcast also available on:

Interview with Adam DeVore, MD, MHS

Podcast also available on:

Interview with Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA

Dr. Hallberg is a nationally and internationally recognized expert in the field of carbohydrate restriction for type 2 diabetes, and part of the largest and longest trial to date in this field. In this interview Dr. Hallberg discusses the evidence behind ketogenic/low carb diets in reducing cardiometabolic risk and much more. Recorded May 5, 2021.

Podcast also available on:

Interview with Dr. Louis Aronne

Dr. Louis Aronne, Professor of Metabolic Research and Medical Director of the Comprehensive Weight Control Center at Weill Cornell Medicine in New York presents on the evolving landscape of obesity management.

Podcast also available on:

Interview with Dr. Chip Lavie

Dr. Carl Lavie, Professor of Medicine and Medical Director of Cardiac Rehabilitation and Prevention, as well as Director of Stress Testing Laboratory at John Ochsner Heart and Vascular Institute in New Orleans, LA discusses the impacts of COVID-19 in obesity management.

Podcast also available on:

Interview with Dr. Ahmed M. Soliman, MD

Dr. Ahmed Soliman, Associate Medical Director at Houston Methodist DeBakey Cardiology Associates in Houston, TX. Listen in as Dr. Soliman discusses the role of digital health tools and telemedicine in general, given the impacts of the COVID-19 pandemic.

Podcast also available on:

Interview with Dr. Jay H. Shubrook, DO, FACOFP, FAAFP

Listen in as Dr. Jay Shubrook, a family physician and diabetes specialist, as well as Professor and Director of Clinical Research at Touro University California in Vallejo California discusses the impact of COVID-19 on diabetes management, as part of a special symposium that will discuss the impact of COVID-19 on cardiometabolic risk

Podcast also available on:

COVID-19 Disparities

Listen to CMHC’s Senior Planning Committee Member and Spring 2021 Keynote, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, share his insights and clinical pearls regarding the disproportionate burden and disparities during COVID-19 pandemic.
RECORDED MARCH 2, 2021

Podcast also available on:

Interview with Dr. Harold Bays

Dr. Harold Bays, Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center as well as Your Body Goal in Louisville, KY., and Chief Science Officer of Obesity Medicine Association shares his insight on obesity pharmacotherapy, cardiometabolic consequences of obesity as well as how the COVID-19 pandemic impacts obesity management.
RECORDED FEBRUARY 22, 2021

Podcast also available on:

Increased Statin Sensitivity in East Asian Patients with Leslie Cho, MD

Since the month of May is celebrated as Asian Pacific Heritage Month, in this podcast, we had an opportunity to talk with Dr. Leslie Cho, Professor of Medicine and Head of Preventive Cardiology and Rehabilitation at the Cleveland Clinic, Ohio, about the prevalence and management of statin intolerance particularly in individuals of East Asian descent.
RECORDED MAY 28, 2020

Podcast also available on:

COVID-19 and Obesity with Robert Eckel, MD

In this podcast, CMHC Chair Robert Eckel, MD, co-president of the American Diabetes Association and Professor of Medicine at University of Colorado in Aurora, discusses the connections between obesity and COVID-19, as well as some updates on diabetes therapy in patients with diabetes and COVID-19.
RECORDED APRIL 27, 2020

Podcast also available on:

The Impact of COVID-19 in Patients With Diabetes

In this podcast, CMHC chair Dr. Anne Peters, Professor of Medicine and Director of Clinical Diabetes Programs at the University of Southern California in LA, discusses the impact of COVID-19 in patients with diabetes
RECORDED MARCH 25, 2020

Podcast also available on:

COVID-19, Cardiac Injury, and Statin Therapy with Christie Ballantyne, MD

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.
RECORDED APRIL 1, 2020

Podcast also available on:

COVID-19 and Cardiovascular Disease

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.
RECORDED MARCH 27, 2020

Podcast also available on:

The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19

Listen to CMHC’s Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEs and ARBs should be withdrawn in patients with COVID-19.
RECORDED MARCH 26, 2020

Podcast also available on: